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Abstract
The Na+, K+-ATPase (NKA) is an ubiquitous enzyme consisting of   
α, β and γ subunits, and is responsible for the creation and main-
tenance of the Na+ and K+  gradients across the cell membrane by 
transporting 3 Na+ out and 2 K+ into the cell. Sodium pump regula-
tion is tissue as well as isoform specific. Intracellular messengers 
differentially regulate the activity of the individual NKA isozymes. 
Regulation of specific NKA isozymes gives cells the ability to pre-
cisely coordinate NKA activity to their physiological requirements. 
It is the only known receptor for the cardiac glycosides used to 
treat congestive heart failure and cardiac arrhythmias. Endogenous 
ligands structurally similar to cardiac glycosides may act as natu-
ral regulators of the sodium pump in heart and other tissues. Iden-
tification of naturally occurring regulators of  NKA could initiate 
the discovery of new hormone-like control systems involved in the 
etiology of selected disease processes, hence the importance of un-
derstanding the relation of the sodium pump and its ligands to dis-
ease. Diabetes has a marked effect on the metabolism of a variety 
of tissues and because the NKA is critical for the membrane poten-
tial and many transports, a change in its activity in diabetes would 
have profound consequence in these tissues. NKA is also involved 
in hypertension, salt balance, cardiovascular and renal disorders, 
sperm capacitation, cell volume regulation, apoptosis, rheumatoid 
arthritis, sepsis, neurological disorders, lung edema clearance and 
preeclampsia. NKA activity and expression in the collecting duct 
of kidney are modulated physiologically by hormones like aldoste-
rone, vasopressin, and insulin. NKA enzyme activity and subunit 
levels are re  duced in carcinoma, NKA-β levels were highly reduced 
in an invasive form of human renal clear cell carcinoma, androgen-
dependent prostate cancer, in early stages of urothelial cancer, as 
well as in poorly differentiated, highly motile carcinoma cell lines 
obtained from various tissues suggesting a functional link between 
reduced NKA-β ex  pression and cancer progression. It could be a 
target for the development of anticancer drugs as it serves as a sig-
nal transducer, it is a player in cell adhesion and its aberrant expres-
sion and activity are implicated in the development and progression 
of different cancers.
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Introduction
The Na+, K+-ATPase (NKA) is an ubiquitous enzyme con-
sisting of  α, β and γ subunits, and is responsible for the cre-
ation and maintenance of the Na+ and K+  gradients across 
the cell membrane by transporting 3 Na+ out and 2 K+ into 
the cell. Most living cells have a high concentration of intra-
cellular K+ and a low concentration of intracellular Na+. This 
is in contrast to the outside of the cell, where there is a high 
concentration of extracellular Na+ and a low concentration of 
extracellular K+. Thus, a concentration gradient exists for the 
loss and gain of intracellular K+ and Na+, respectively. This 
gradient is maintained through the activity of various ionic 
channels and transporters, but predominantly the activity of 
the NKA. A typical cell keeps a resting membrane potential 
of -70 mV. Potassium ions will tend to flow out of the cell, 
since their equilibrium potential (-91 mV) is more negative 
than the transmembrane potential. Sodium ions have a very 
strong force driving them into the cell, since both the chemi-
cal  and  electrical  gradients  (equilibrium  potential  of  +64 
mV) favor Na+ uptake. The enzymatic manifestation of the 
sodium pump is the NKA. This enzyme, found in all mam-
malian cell membranes, is necessary for proper cellular func-
tion since it helps to preserve the ionic gradients across the 
cell membrane and thus the membrane potential and osmotic 
equilibrium of the cell [1]. This function is crucial for cell 
survival and body homeostasis since the Na+ gradient is used 
as an energy source to transport ions or solutes, and is at the 
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origin of the vectorial Na+ reabsorption in the kidney and 
of action potentials in excitable tissues. It is putative com-
ponent of a biological membrane that affects the transfer of 
these ions from one side of the membrane to the other. It is 
active transport which is responsible for the well-established 
observation that cells contain relatively high concentrations 
of potassium ions but low concentrations of sodium ions. 
The mechanism responsible for this is the sodium-potassium 
pump which moves these two ions in opposite directions 
across the plasma membrane. This was investigated by fol-
lowing the passage of radioactively labeled ions across the 
plasma membrane of certain cells. It was found that the con-
centrations of sodium and potassium ions on the two other 
sides of the membrane are interdependent, suggesting that 
the same carrier transports both ions. It is now known that 
the carrier is an ATPase and that it pumps three sodium ions 
out of the cell for every two potassium ions pumped in.  It 
catalyzes the transfer of 2 K+ from the extracellular space 
into the cell and the extrusion of 3 Na+, while hydrolyzing 
adenosine  triphosphate  (ATP)  to  adenosine  diphosphate 
(ADP) and inorganic phosphate (Pi). The transport of 3 Na+ 
for 2 K+ across the membrane, through the means of the so-
dium pump, maintains transmembrane gradients for the ions 
and produces a convenient driving force for the secondary 
transport of metabolic substrates such as amino acids and 
glucose. In addition, the nonequivalent transport is electro-
genic and leads to the generation of a transmembrane electri-
cal potential allowing cells to become excitable. The “pump” 
couples the energy released in the intracellular hydrolysis 
of adenosine triphosphate (ATP) to the transport of cellular 
ions, a major pathway for the controlled translocation of so-
dium and potassium ions across the cell membrane. NKA 
therefore controls directly or indirectly many essential cel-
lular functions, e.g., cell volume, free calcium concentration, 
and membrane potential. Regulation of this enzyme (trans-
porter) and its individual isoforms is thought to play a key 
role in the etiology of some pathological processes.
The transport ATPases were reported in 1957 by a Dan-
ish scientist named J.C. Skou [2].  This was the first report 
suggesting that Na+ and K+ transport across the plasma mem-
brane is linked to activation of NKA (otherwise known as so-
dium pump). Forty years later, in 1997, J.C. Skou shared the 
Nobel Prize in Chemistry for his discovery of NKA. Trans-
port ATPases have been classified into three categories: (1) 
P-type ATPases that catalyze reactions using a phosphory-
lated intermediate; (2) V-type ATPases that are found to be 
associated with vacuoles; and (3) F-type ATPases that are 
also known as ATP synthases. The primary role of the P-type 
NKA is to maintain the homeostasis of Na+ and K+ ions in 
eukaryotic cells.
The purpose of this review is to highlight the structure of 
NKA and the relevant literature information showing its in-
volvement in various patho-physiological processes, which 
may help others for further exploration to control diseases 
where NKA is involved.
The NKA contains 1 principal catalytic subunit, des-
ignated α and 1 sugar-rich auxiliary subunit, designated β. 
There is an associated subunit γ present only in some tissues. 
The α-subunit has a molecular mass of about 110 kDa with 
10 transmembrane segments. Its four distinct isoforms have 
been  identified. The  differences  of  amino  acid  sequences 
among the isoforms are minor. They are each coded by a dif-
ferent gene, some of them located on different chromosomes 
[3, 4]. The various isoforms differ primarily in their tissue 
distribution, α1 predominating in several tissues, including 
kidney, nerves, and lung; α2 in skeletal muscle and heart; 
α3 in the brain; and α4, which is apparently localized to tes-
tis and specifically to spermatozoa [5]. The α-subunit car-
ries the catalytic function of the enzyme, and this is reflected 
in its possession of several binding and functional domains. 
The β-subunit has a molecular weight of about 55 kDa, with 
a single membrane crossing. Its three isoforms have been 
identified. As α isoforms, β isoforms have a tissue-specific 
distribution,  β1  is  ubiquitous,  β2  is  expressed  in  skeletal 
muscle and heart, and β3 in testis and central nervous system 
[6].  It is clear that an essential role for β subunit is in the de-
livery and the appropriate insertion of α subunit in the mem-
brane [7]. In recent years, a variety of studies suggest that 
the β subunit may be more intimately involved in the mecha-
nism of active transport and may be a regulatory subunit [5, 
8].  The γ subunit is a hydrophobic and a single-membrane 
crossing protein of molecular weight about 12 kDa [Fig. 1]. 
Although much is not known about its function, it does 
appear to be obligatorily associated with the αβ complex 
[9]. Further, the other family of small membrane proteins 
i.e. FXYD proteins exist widely distributed in mammalian 
tissues with prominent expression in tissues that perform 
fluid and solute transport or that are electrically excitable. 
The FXYD protein family is a family of small membrane 
proteins that share a 35-amino acid signature sequence do-
main, beginning with the sequence PFXYD and containing 7 
invariant and 6 highly conserved amino acids. The approved 
human gene nomenclature for the family is FXYD-domain 
containing ion transport regulator. Recent experimental evi-
dence suggests that at least five of the seven members of 
this family, FXYD1 (phospholemman), FXYD2 (γ-subunit 
of NKA), FXYD3 (Mat-8), FXYD4 (CHIF), and FXYD7, 
are auxiliary subunits of NKA and regulate NKA activity in 
a tissue. These results highlight the complexity of the regu-
lation of Na+ and K+ handling by NKA, which is necessary 
to ensure appropriate tissue functions such as renal Na+ re-
absorption, muscle contractility, and neuronal excitability. 
Moreover, a mutation in FXYD2 has been linked to cases 
of human hypomagnesemia, indicating that perturbations in 
the regulation of NKA by FXYD proteins may be critically 
involved in pathophysiological states [10].  
The  γ-subunit  is  a  member  of  the  membrane  protein 
family that consists of proteins having only one transmem-
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brane domain. Expressed in oocytes, such proteins serve as 
ion channels [11]. Further, that the addition of γ-subunit to 
NKA changes its affinity to monovalent cations: the α1β1γ 
complex has lower affinity to Na+ and K+ than the α1β1 com-
plex [12]. In addition, there is apparently a family of pro-
teins that are relatives (isoforms) of this subunit: two of them 
found in rat kidney have seven different amino acid residues 
in the N terminal domain, and one of these two forms can be 
acylated [13]. Isoforms of the γ-subunit have different elec-
trophoretic mobility and differently affect the affinity of the 
α1β1γ complex for Na+ [12, 13]. These data suggest that the 
γ-subunit in kidney is a factor regulating the sensitivity of 
NKA to transported cations.   
In 2005, Capasso et al [14] have reported that hyper-
tonicity-mediated upregulation of the γ-subunit of NKA is 
dependent on both the c-Jun NH2-terminal kinase (JNK) and 
the phosphoinositide 3-kinase (PI3 kinase) pathways. They 
explored the mechanisms whereby these pathways regulate 
the expression of the γ-subunit in inner medullary collect-
ing duct cells (IMCD3). Inhibition of JNK with SP-600125 
(20 mM, an anthrapyrazolone inhibitor of JNK), a concen-
tration that causes an approximately 95% inhibition of hy-
pertonicity-stimulated JNK activation, markedly decreased 
the amount of the γ-subunit in response to 550 mosmol/kg 
H2O for 48 h. This was accompanied by a parallel decrease 
in  the  γ-subunit  mRNA. The  rate  at  which  the  γ-subunit 
mRNA decreased was unaffected by actinomycin D. In con-
trast, inhibition of PI3 kinase with LY-294002 (a selective 
PI3K inhibitor) results in a marked decrease in the amount 
of γ-subunit protein but without alteration in γ-subunit mes-
sage. The rate at which the γ-subunit protein decreased was 
unaffected by cyclohexamide. Transfection of IMCD3 cells 
with a γ-subunit construct results in the expression of both 
γ-subunit message and protein. However, in cortical collect-
ing duct cells (M1 cells) such transfection resulted in expres-
sion of only the message and not the protein. They concluded 
that JNK regulates the γ-subunit at the transcriptional level 
while PI3 kinase regulates γ-subunit expression at the trans-
lational level. There is also post-transcriptional cell specific-
ity in the expression of the γ-subunit of NKA.
The γ-subunit has been characterized as a fine-tuning 
modulator  of  the  NKA  expressed  in  kidney  tissues. This 
small single transmembrane domain protein interacts with 
the γ-subunit of NKA to increase affinity for ATP and de-
crease affinity for Na+ allowing medullary cells to contin-
ue  pump  activity  under  reduced  cellular ATP  levels. The 
γ-subunit is undetectable in kidney cell cultures grown un-
der isotonic conditions and expression is induced with acute 
or chronic exposure to hypertonicity. The gamma subunit 
demonstrates  remarkable  regulatory  complexity  includ-
ing induction by chloride ions rather than sodium, the dif-
ferential expression of at least 2 isoforms, involvement of 
separate MAP (mitogen-activated protein) kinase signaling 
pathways for transcription (JNK) and translation (PI3K) as 
well as cell type regulation of expression. Mutation in the 
transmembrane domain of the γ-subunit has been implicated 
in cases of primary hypomagnesemia. Alternative roles have 
been established for the γ-subunit in embryonic development 
and quite possibly additional functions in cell signaling as 
yet unrecognized may be possible [15].
NKA couples the energy released in the intracellular hy-
drolysis of ATP to the export of three intracellular sodium 
ions and the import of two extracellular potassium ions. The 
continuous operation of this macromolecular machine en-
sures the generation and maintenance of concentration gra-
dients of sodium and potassium across the cell membrane 
(Fig. 2). This electrochemical gradient provides energy for 
the membrane transport of metabolites, nutrients, and ions. 
This electrochemical gradient is essential also for regulation 
of cell volume and intracellular pH and for the action po-
tential of muscle and nerve [9]. This enzyme is responsible 
of about 15% to 20% of resting energetic expense in whole 
Figure 1. Diagrammatic representation of NKA consisting of 2α, 2β, 2γ-subunits within the biomembrane.
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organism [16].
Because several cellular transport systems are coupled 
to the movement of sodium and, therefore, to the function 
of NKA, this enzyme is the target of multiple regulatory 
mechanisms activated in response to changing cellular re-
quirements. The demand for modulators of the NKA is likely 
to be greatest in tissues in which disturbances of the intra-
cellular alkali cation concentration underlie their specialized 
functions. Prime examples are the changes in enzyme ac-
tivity that occur in response to physiological stimuli such 
as nerve impulse propagation and exercise [9]. Generally, 
regulation of NKA is brought about by increased message 
transcription, increased recruitment of heterodimers to the 
cell membrane, modifications of heterodimers trafficking, 
and half-life in the cell membrane, and by direct regulation 
of enzymes in the cell membrane. Direct regulation of the 
cell membrane enzymes results from phosphorylation and 
dephosphorylation by protein kinases and protein phospha-
tases. Thus, depending on the tissue, activation of protein 
kinases can induce an increase or decrease in sodium pump 
activity [17]. Moreover, sodium pump regulation seems to 
be tissue but also isoform specific [18]. Firstly, the simplest 
and most straightforward determinants of pump activity are 
the concentrations of substrates- Na+, K+, and ATP. Some 
hormones appear to alter NKA activity by modifying its ap-
parent affinity for sodium or by enhancing the sodium in-
flux. The ATP concentration is generally saturating for the 
enzyme in most cells. However, in some tissues and under 
certain conditions, ATP levels may go down to sub-satu-
rating levels, such as in kidney medulla, which functions 
under near anoxic conditions [19]. Secondly, endogenous 
cardiotonic steroids such as ouabain inhibits specifically the 
sodium pump, whereas interactions of the pump with com-
ponents of the cytoskeleton permits the correct processing 
and targeting of sodium pumps to the appropriate membrane 
compartment [9]. Thirdly, NKA is a transmembranous en-
zyme and many reports have focused on the role of mem-
brane lipids. In general, lipids that promote bilayer formation 
of physiological thickness and increased fluidity tend to sup-
port optimal NKA activity, as do negatively charged lipids 
such  as  phosphatidylserine  and  phosphatidylglycerol  [20, 
21, 22]. The effects of cholesterol on enzyme activity are 
often also related to membrane fluidity [23]. Free fatty acids 
present in the membranes or as the products of phospholi-
pases and eicosanoids tend to have various regulatory effects 
on NKA activity. Lastly, the enzyme activity is subjected to 
both short- and long-term regulation by several hormones. 
Short-run regulation involves generally direct effects on the 
kinetic behavior of the enzyme or translocation of sodium 
pumps between intracellular stores and the plasma mem-
brane. Long-run regulation induces de novo NKA synthesis 
or degradation. Corticosteroids and particularly aldosterone 
sustains a long-run increase in expression of sodium pumps, 
whereas catecholamines have various affects on pump activ-
ity, with an inhibitory effect of dopamine and a stimulating 
effect of epinephrine and norepinephrine [9]. Insulin mainly 
stimulates the NKA activity by increasing the translocation 
of sodium pumps from intracellular stores to the cell surface, 
the cytoplasmic sodium content, and also the apparent af-
finity of the enzyme for sodium [24]. Recently, C-peptide 
(a peptide that is made when proinsulin is split into insulin 
and C-peptide; –one C-peptide for each insulin molecule) 
has been found to stimulate the NKA activity in renal tubular 
from control rat [25] and in sciatic nerve from diabetic rat 
Figure 2. Diagrammatic representation of the transport of Na+[3] and K+[2] by NKA across the biomembrane consuming 
one molecule of ATP.
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[26]. In human diabetes, the decrease of availability of both 
insulin and C-peptide could change the regulatory equilib-
rium of NKA activity in favor of a decrease.
Isoenzymic forms of NKA
As mentioned above the NKA is characterized by a com-
plex molecular heterogeneity that results from the expres-
sion  and  differential  association  of  multiple  isoforms  of 
both its α- and β-subunits. At present, as many as four dif-
ferent α-polypeptides (α1, α2, α3, and α4) and three distinct 
β-isoforms (β 1, β2, and β3) have been identified in mam-
malian cells. The stringent constraints on the structure of the 
sodium pump isozymes during evolution and their tissues 
specific and developmental pattern of expression suggests 
that the different NKA have evolved distinct properties to 
respond to cellular requirements. The kinetic characteristics 
of different NKA isozymes to the activating cations (Na+ and 
K+), the substrate ATP, and the inhibitors Ca2+ and ouabain 
demonstrate that each isoform has distinct properties. In ad-
dition,  intracellular  messengers  differentially  regulate  the 
activity of the individual NKA isozymes. Thus, the regula-
tion of specific sodium pump isozymes gives cells the ability 
to precisely coordinate NKA activity to their physiological 
requirements [27].
Pathophysiological relevance of NKA
Alterations in NKA activity in diabetes
Diabetes has a marked effect on the metabolism of a variety 
of tissues and because the NKA is critical for the membrane 
potential and many transports, a change in its activity in dia-
betes would have profound consequence in these tissues. We 
have observed significant effect of diabetes in the metabo-
lism of diabetic erythrocytes [28-33] and significant decrease 
in the activity of NKA in alloxan induced diabetic rats [30]. 
Erythrocytes of diabetic patients have reduced life span [28], 
altered membrane dynamic properties and increased mem-
brane thermostability. It has also been reported that diabetic 
patients with poor metabolic control have lower erythrocyte 
membrane enzymes activity as compared to healthy control 
subjects [30-32]. The modified proteins have altered func-
tions such as modified enzymatic activities [29-33], lower 
affinities for their receptors [34], etc. In 1976, Das et al [35] 
described a decrease of NKA enzyme activity in sciatic nerve 
of diabetic rat, whereas an increase in enzyme activity was 
found in mucosa of the small intestine of diabetic rat [36]. 
These two examples illustrate the different effect of diabetes 
on NKA depending on the tissues. Tissues can be classified 
in three groups, one principal group in which diabetes in-
duces a decrease in NKA activity, including sciatic nerve, 
lens, heart, and erythrocyte; another group in which diabetes 
causes an increase in enzyme activity, including mucosa of 
the small intestine; and one group with a NKA activity un-
changed or where it exists differences between studies.  
Several mechanisms have been suggested to explain the 
decrease in NKA activity: a depletion of the intracellular pool 
of myo-inositol, an increased flux through the aldose reduc-
tase pathway, and an alteration in protein kinase-C (PKC) 
activity [37]. Other diabetes-induced metabolic changes can 
also down-regulate the enzyme activity, including the in-
crease in oxidative stress, the formation of advanced glyca-
tion products, the nerve growth factor metabolism [38], and 
the disturbance in essential fatty acid metabolism leading to 
an abnormal ω6/ω3 ratio in red blood cell membrane [39].
Moreover, insulin and C-peptide deficiencies can alter 
the long-term regulation of enzyme units expressed at the 
cell surface. The over-expression of α isoforms cannot be 
connected with an increase in enzyme activity; β isoforms 
are necessary to form an active complex. The C-peptide has 
short-term effect on NKA activity by modifying its phos-
phorylation status. Contrary to the down-regulation mecha-
nisms, the mechanisms implicated in the NKA increase in 
some tissues of diabetic rat seems to be related to variations 
on mRNA levels of NKA isoforms. In rat skeletal muscle, 
insulin is able to produce a rapid translocation of preexisting 
α2 NKA from intracellular stores to the plasma membrane 
[40]. This results in the recruitment of additional functional 
Na pumps to the cell surface and increased NKA activity.  
The impairment of NKA activity, mainly secondary to the 
lack of C-peptide, plays probably a role in the development 
of  diabetic  complications.  The  diabetes-induced  decrease 
in enzyme activity would compromise microvascular blood 
flow by affecting microvascular regulation and decreasing 
red blood cell deformability, which lead to increased blood 
viscosity. C-peptide infusion restored red blood cell deform-
ability  and  microvascular  blood  flow  concomitantly  with 
NKA activity [41]. In 2000, the same group had reported that 
insulin and C-peptide directly act on erythrocyte NKA, re-
storing the decreased tissue NKA activity observed in type-1 
diabetic patients [42]. Low C-peptide level is considered to 
be responsible for low NKA activity in the red blood cells. 
Short-term  C-peptide  infusion  to  type  1  diabetic  patients 
restores normal NKA activity. Islet transplantation, which 
restores endogenous C-peptide secretion, enhances NKA ac-
tivity proportionally to the rise in C-peptide. This C-peptide 
effect is not indirect. In fact, incubation of diabetic red blood 
cells with C-peptide at physiological concentration leads to 
an increase of NKA activity. In isolated proximal tubules of 
rats or in the medullary thick ascending limb of the kidney, 
C-peptide stimulates in a dose-dependent manner NKA ac-
tivity. The defect in ATPase is strongly related to diabetic 
neuropathy. Patients with neuropathy have lower ATPase ac-
tivity than those without. The diabetes-induced impairment 
in NKA activity is identical in red blood cells and neural 
tissue. Red blood cell ATPase activity is related to nerve 
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conduction velocity in the peroneal and the tibial nerve of 
diabetic patients. C-peptide infusion to diabetic rats increas-
es endoneural ATPase activity in rat. Because the defect in 
NKA activity is also probably involved in the development 
of diabetic nephropathy and cardiomyopathy, physiological 
C-peptide infusion could be beneficial for the prevention of 
diabetic complications [41].
In  order  to  elucidate  the  causal  relationship  between 
NKA and diabetic nephropathy, the erythrocyte enzyme ac-
tivity was studied in type-2 diabetic patients (with micro-
albuminuria and without microalbuminuria) and in control 
subjects. NKA activity was significantly reduced in diabetic 
patients with hypertension and in microalbuminuric patients 
who had higher systolic BP and greater frequency of parental 
hypertension than those without microalbuminuria. More-
over, the enzyme activity in diabetic patients with parental 
hypertension  was  significantly  reduced  [43].  Contrary  to 
this, in other research groups, the NKA activity was found 
to be higher in the diabetic than in the normal group, but the 
number of Na-pumps was not significantly different [44, 45]. 
This increased activity of erythrocyte Na-pump in diabetes 
mellitus might suggest an increase of cation permeability as-
sociated with a possible disorder in the diabetic membrane. 
Conversely, the Na pumping activity (estimated from both 
NKA and ouabain-binding) was observed by others to be 
significantly decreased in type-1 and type-2 diabetic patients 
and to retain the insulin sensitivity only in young type-1 dia-
betics [46]. A significant reduction of NKA activity in eryth-
rocyte membranes of type-1 diabetic patients, compared with 
matched controls, with similar contents of erythrocyte Na+ 
and K+ ion was also reported; when erythrocyte membranes 
of diabetic patients were incubated with their own plasma 
(probably containing higher concentration of a specific acti-
vator of NKA enzyme), a significant increase was found in 
enzyme activity, this effect being not influenced by the meta-
bolic control [47]. Rabini and co-workers [48] observed that 
the structure of erythrocyte membranes, obtained from type-
1 diabetic patients, showed a uncompetitive inhibition of the 
NKA, linked to the presence of conformational modifications 
of the protein. Modifications of the interactions between the 
enzymatic  subunits  and  the  membrane  lipid  environment 
might be at the basis of the NKA alteration in diabetes. With 
a microcalorimetric study, which allowed a direct measure-
ment of the NKA activity in living red blood cells, a reduced 
Na, K-pump activity in diabetic patients were reported with 
a slower velocity of response to ouabain [49]. In type 1 dia-
betic patients, supplementation of C-peptide was shown to 
improve endothelium dependent vasodilatation in an NO-de-
pendent pathway in different vascular compartments. In ad-
dition, it was observed that C-peptide administration in type 
1 diabetic patients resulted in a redistribution of skin blood 
flow by increasing nutritive capillary blood flow in favor to 
subpapillary blood flow. Impaired NKA in an  other feature 
of diabetes mellitus in many cell types and is believed to 
be a pivotal regulator of various cell func  tions. C-peptide 
supplementation has been shown to re  store NKA activity in 
different cell types during in vitro and in vivo investigations. 
In type 1 diabetic pa  tients, C-peptide supplementation was 
shown to increase erythrocyte NKA activity by about 100%. 
A linear relationship was found between plasma C-peptide 
levels and erythrocyte NKA activity. In small capillaries, mi-
crovascular blood flow was increasingly deter  mined by the 
rheologic properties of erythrocytes. Using laser-diffractos-
copy a huge improvement in erythrocyte deformability was 
observed after C-peptide administra  tion in erythrocytes of 
type 1 diabetic patients. Inhibition of the NKA by ouabain 
completely abolished the effect of C-peptide on erythrocyte 
deformability. Conclu  sively, C-peptide improves microvas-
cular function and blood flow in type 1 diabetic patients by 
interfering with vascular and rheological components of mi-
crovascular blood flow [50].
NKA correlation with hypertension, impact on salt bal-
ance and vascular contractility
The sodium pump is the only known receptor for the car-
diac glycosides used to treat congestive heart failure and 
cardiac arrhythmias. This suggests that endogenous ligands 
structurally similar to cardiac glycosides may act as natu-
ral regulators of the sodium pump in heart and other tissues. 
Identification of naturally occurring regulators of NKA could 
initiate the discovery of new hormone-like control systems 
involved in the etiology of selected disease processes, hence 
the importance of understanding the relation of the sodium 
pump and its ligands to disease. The NKA contains a bind-
ing site for cardiac glycosides, such as ouabain, digoxin, and 
digitoxin, which is highly conserved among species ranging 
from Drosophila to humans. 
Although advantage has been taken of this site to treat 
congestive heart  failure with  drugs  such  as  digoxin, it  is 
unknown whether this site has a natural function in vivo. 
However, this site plays an important role in the regulation 
of blood pressure, and it specifically mediates adrenocorti-
cotropic  hormone  (ACTH)-induced  hypertension  in  mice. 
Dostanic-Larson et al [51] used genetically engineered mice 
in which the NKA α2 isoform, which is normally sensitive to 
cardiac glycosides, was made resistant to these compounds. 
Chronic  administration  of ACTH  caused  hypertension  in 
mice but not in mice with an ouabain-resistant α2 isoform of 
NKA. This finding demonstrates that the cardiac glycoside 
binding site of the NKA plays an important role in blood 
pressure regulation, most likely by responding to a naturally 
occurring ligand. Because the α1 isoform is sensitive to car-
diac glycosides in humans, they developed mice in which the 
naturally occurring ouabain-resistant α1 isoform was made 
ouabain-sensitive.  Mice  with  the  ouabain-sensitive  “hu-
man-like” α1 isoform and an ouabain-resistant α2 isoform 
developed  ACTH-induced  hypertension  to  greater  extent 
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than control animals. This result indicates that the cardiac 
glycoside binding site of the α1 isoform can also mediate 
ACTH-induced hypertension. Conclusively, these data pro-
vide conclusive evidence that the cardiac glycoside binding 
site, which mediates the pharmacological effects of digitalis 
and related drugs used in the treatment of congestive heart 
failure, is also the receptor for endogenous ligands involved 
in the regulation of cardiovascular function in vivo. Such re-
sults support the hypothesis that a steroid hormone may exist 
that regulates blood pressure through the interaction with the 
NKA.
The genetic and environmental heterogeneity of essen-
tial hypertension is responsible for the individual variability 
of antihypertensive therapy. An understanding of the molec-
ular mechanisms underlying hypertension and related organ 
complications is a key aspect for developing new, effective, 
and safe antihypertensive agents able to cure the cause of 
the disease. Two mechanisms, among others, are involved 
in determining the abnormalities of tubular Na+ reabsorp-
tion observed in essential hypertension: the polymorphism 
of the cytoskeletal protein alpha-adducin and the increased 
circulating levels of endogenous ouabain (EO). Both lead to 
increased activity and expression of the renal Na+-K+ pump, 
the driving force for tubular Na transport. Morphological and 
functional vascular alterations have also been associated with 
EO. Rostafuroxin (PST 2238) is a new oral antihypertensive 
agent able to selectively antagonize EO, adducin pressor and 
molecular effects. It is endowed with high potency and effi-
cacy in reducing blood pressure and preventing organ hyper-
trophy in animal models representative of both adducin and 
EO mechanisms. At molecular level, in the kidney, Rostafu-
roxin antagonizes EO triggering of the Src-epidermal growth 
factor receptor (EGFr)-dependent signaling pathway leading 
to renal Na+-K+ pump, and ERK tyrosine phosphorylation 
and activation. In the vasculature, it normalizes the increased 
myogenic tone caused by nanomolar ouabain. A very high 
safety ratio and an absence of interaction with other mecha-
nisms involved in blood pressure regulation, together with 
initial evidence of high tolerability and efficacy in hyperten-
sive patients, indicate Rostafuroxin as the first example of a 
new class of antihypertensive agents designed to antagonize 
adducin and EO-hypertensive mechanisms [52].
Weidmann and Ferrari have reported [53] that not only 
do  type  I  (insulin-depen  dent)  diabetic  individuals  have  a 
familial predisposition for essential hypertension, but also 
normotensive offspring of parents who are non-diabetic but 
have essential hyper  tension show increased concentrations 
of plasma insulin and reduced insulin sensitivity; moreover, 
Na+ retention is characteristic of both type I and type II (non-
insulin-dependent) diabetics. These authors also report that 
intra  cellular calcium is increased in adipocytes, in part via 
insulin’s inhibition of Ca2+, Mg2+-ATPase, and that insu  lin 
may increase renal sodium retention and influence the activ-
ity of transmembrane electrolyte pumps. Insulin reg  ulation 
of vascular NKA gene expression has been reported [54] as 
an important factor in the development of hypertension in 
diabetes. The mRNA encoding both the α1 and α2 isoforms 
was identified in vascular smooth muscle cells derived from 
embryonic rat thoracic aorta. Although the predominant iso-
form was α1, only the concentrations of the α2 isoform in-
creased in response to insulin treatment. The overall increase 
in  ouabain-inhibitable  NKA  activity  in  vascular  smooth 
muscle cells in response to insulin treat  ment suggests that, 
in the absence of insulin or in insulin-resistant states, NKA 
activity could decrease, re  sulting in increased vascular con-
tractility and blood pressure.  
Renal NKA activity is bidirectionally regulated by na-
triuretic and antinatriuretic hormones, and a shift in the bal-
ance between these forces may lead to salt retention and 
hypertension. Dopamine plays a key role in this interactive 
regulation. By inhibiting vascular NKA activity, an excess 
of circulating ouabain may increase calcium concentration 
in vascular cells and lead to increased vascular contractility. 
Finally, mutations in cytoskeleton proteins may stimulate re-
nal NKA activity by way of protein/protein interaction and 
lead to salt retention and hypertension [55]. Further, that the 
sodium transporters and NKA are segregated in membrane 
lipid and non-lipid raft microdomains that regulate their ac-
tivities and trafficking via cytoskeletal proteins. The increase 
in renal proximal tubule ion transport in polygenic hyperten-
sion is primarily due to increased activity of NHE3 (sodium 
hydrogen exchanger isoform 3) and Cl/HCO3 exchanger at 
the luminal/apical membrane and a primary or secondary 
increase in NKA activity.   The increase in renal proximal 
tubule ion transport in hypertension is due to increased ac-
tions by prohypertensive factors that are unopposed by anti-
hypertensive factors [56].  
Alterations in NKA activity in cardiovascular and renal 
disorders  
The dysregulation of chief electrolytes especially sodium, 
potassium and calcium has a characteristic role in the car-
diovascular and renal diseases. There occurs altered sodium 
and  potassium  concentrations  in  cardiovascular  and  renal 
patients primarily due to impaired NKA activity. Alterations 
take place in erythrocyte and plasma ionic environment in 
cardiovascular and renal patients. Under physiological con-
ditions, NKA pump is the principal transporter, accounting 
for 1.4-2.0 mmol/rbc/hr. The Na+, K+-cotransport and so-
dium leak pathway are each responsible for approximately 
0.2 mmol/rbc/hr. Most of the studies indicate that elevation 
of intracellular sodium and potassium was associated with a 
reduced activity of erythrocyte NKA pump [57]. Inhibition 
of NKA activity is the main factor as in most of the cardio-
vascular diseases, inhibited or reduced ATPase activity has 
been observed. The decreased serum sodium and increased 
serum potassium concentrations in renal patients have also 
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been reported indicating that hyperkalemic state might have 
developed from a shift of potassium from intracellular to ex-
tracellular compartment or it could have been secondary to 
decreased renal potassium excretion. This increased potassi-
um could also result from decreased renin production, which 
affects the aldosterone synthesis due to adrenal defect, which 
then would produce renal tubular secretory defect leading to 
abnormal distribution of potassium between intra and extra-
cellular compartments [58].  
In renal tubular epithelial cells, the expression and func-
tion of α1/β1 isoforms of the NKA are key in determining 
sodium ion reabsorption from the glomerular filtrate. Vari-
able  levels  of  endogenous  sodium  pump  inhibitors  seem 
to regulate this reabsorption, both by inhibiting enzymatic 
function  and  through  altering  plasmalemmal  expression, 
and, thus, regulate renal sodium handling. The sodium pump 
also participates in the maintenance of intracellular sodium 
concentrations necessary for smooth muscle cell and cardiac 
myocyte  functions  [27].  Further,  that  the  cardiotonic  ste-
roids (CTS) are essential participants in this regulation. In 
the classic or “ionic” signaling pathways for sodium pump 
function, it is quite clear how the inhibited sodium pump, 
coupled to the Na+/Ca2+-exchanger, may cause an increase in 
intracellular sodium, which in turn may lead to an increase 
in cytosolic calcium, the latter being a key second messenger 
for a variety of cell functions. The three classic features of 
NKA (the pump, the enzyme, and the receptor to cardiotonic 
steroids) are being understood in substantially greater detail, 
and, in some aspects, have undergone a paradigm shift in 
understanding. In particular, there is evidence that extremely 
low concentration of cardiotonic steroids, which are unlikely 
to inhibit the enzymatic function of the sodium pump [59, 
60], are able to initiate several signaling pathways, which 
may be extremely important for a variety of cell functions.  
One single mechanism of the interaction of cardiac gly-
cosides with the Na+ pump cannot explain the complexity of 
cellular responses resulting in cardiac inotropy, arterial hy-
pertension, and remodeling of the circulatory system in asso-
ciation with tissue proliferation, as well as apoptotic process-
es. The well-known Na+-lag hypothesis, which assumes that 
inhibition of the α2-isozyme of NKA leads to an increase 
in Ca2+concentration, may explain short-term and inotropic 
actions of CTS. However, long-term effects leading to acti-
vation of genes and resulting in activation of cell prolifera-
tion, as well as apoptotic processes, are better described by 
the NKA signalosome hypothesis, which involves specific 
activation of signal transduction machinery. Depending on 
the gene expression pattern of the target cell, endogenous 
and  exogenous  cardiac  glycosides  may  induce  different 
physiological responses affecting not only the physiological 
action of cells of the circulatory system and an organism’s 
salt metabolism but, also, the growth of cancer cells. Car-
diotonic steroids (CTS), long used to treat heart failure, are 
endogenously produced in mammals. Among them are the 
hydrophilic cardenolide ouabain and the more hydrophobic 
cardenolide digoxin, as well as the bufadienolides, marino-
bufagenin and telecinobufagin. Bufalin and oleandrin or the 
cardenolide analog UNBS-1450 block tumor cell prolifera-
tion and induce apoptosis at low concentrations in tumors 
with constitutive activation of NF-kappaB [61].  
The NKA actively transports Na+ out and K+ into the 
myocyte. It is the receptor for cardiac glycosides exerting 
its positive inotropic effect by inhibiting enzyme activity, 
decreasing the driving force for the Na+/Ca+-exchange and 
increasing cellular content and release of Ca+ during depolar-
ization. The specific binding capacity for cardiac glycosides 
is utilized as a tool for NKA quantification with high accu-
racy and precision. In treatment of patients with heart failure 
cardiac glycosides improve symptoms and reduce the need 
for hospitalization without affecting mortality. In endomyo-
cardial  biopsies  from  patients  with  compromised  cardiac 
function total NKA concentration is decreased by about 40% 
and a correlation between decrease in heart function and 
decrease in NKA concentration exists. At the subunit level, 
the α1-, α3- and β1-proteins are reduced in human heart fail-
ure. During digitalization about 30% of remaining Na+, K+-
pumps are occupied by digoxin. Thus, a total of not less than 
half the Na+, K+-pumps may be out of function in the myo-
cardium of digitalized heart failure patients. It is still a mat-
ter of debate whether a digitalis-like factor exists. There is 
a pressing need for the identification of its precise chemical 
structure, properties and quantitative relation to the NKA. 
It is recommended that cardiac glycosides are prescribed to 
heart failure patients who are still having heart failure symp-
toms after institution of mortality reducing therapy. Cardiac 
glycoside treatment is still the only safe inotropic drug for 
oral use that improves hemodynamics in patients with com-
promised cardiac function [62]. 
Myocardial NKA is also influenced by other drugs used 
for the treatment of heart failure. Thus, potassium loss dur-
ing diuretic therapy has been found to reduce myocardial 
NKA,  whereas  angiotensin-converting  enzyme  inhibitors 
may stimulate Na/K pump activity. Furthermore, hyperal-
dosteronism induced by heart failure has been found to de-
crease NKA activity. Accordingly, treatment with the aldo-
sterone antagonist, spironolactone, may also influence NKA 
activity.  The  importance  of  Na/K  pump  modulation  with 
heart disease, inhibition in digitalization and other effects of 
medication should be considered in the context of sodium, 
potassium and calcium regulation. It is recommended that 
digoxin be administered to heart failure patients who, after 
institution  of  mortality-reducing  therapy,  still  have  heart 
failure symptoms, and that the therapy is continued if symp-
toms are revealed or reduced. Digitalis glycosides are the 
only safe inotropic drugs for oral use that improve hemody-
namics in heart failure. An important aspect of myocardial 
Na/K pump affection in heart disease is its influence on extra 
cellular potassium KE homeostasis. Two important aspects 
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should be considered: potassium handling among myocytes, 
and effects of potassium entering the extracellular space of 
the heart via the bloodstream. It should be noted that both 
of these aspects of KE homeostasis are affected by regula-
tory aspects, for example, regulation of the Na/K pump by 
physiological and pathophysiological conditions, as well as 
by medical treatments. Digitalization has been shown to af-
fect both parameters. Furthermore, in experimental animals, 
potassium loading and depletion are found to significantly 
affect KE handling. The effects of potassium depletion are 
of special interest because this condition often occurs in pa-
tients treated with diuretics. In human congenital long QT 
syndrome caused by mutations in genes coding for potas-
sium channels, exercise and potassium depletion are well 
known for their potential to elicit arrhythmias and sudden 
death. There is a need for further evaluation of the dynamic 
aspects of potassium handling in the heart, as well as in the 
periphery. It is recommended that resting plasma potassium 
be maintained at around 4 mM/L [63]. There is a tissue-
specific regulation of NKA isoform expression in humans, 
as well as a highly specific regulation of the isoforms dur-
ing disease, for example heart failure. There is also evidence 
for specific biochemical properties of different isoforms of 
the human NKA as well as for a specific functional impact 
on cardiac contractility in mice. Therefore, the isoforms of 
human  NKA  are  not  exchangeable  and  targeting  specific 
isoforms by drugs or gene therapy may promise therapeutic 
benefit in diseases like heart failure or atrial fibrillation [64]. 
Myocardial infarction leads to compensatory ventricular 
remodeling. Disturbances in myocardial contractility depend 
on the active transport of Ca2+ and Na+, which are regulated 
by NKA. Inappropriate regulation of NKA activity leads to 
excessive loss of K+ and gain of Na+ by the cell. The NKA hy-
poactivity may modify the Na+, K+ and Ca2+ transport across 
the sarcolemma resulting in ventricular dysfunction [65]. In 
2004, Dostanic et al have demonstrated that the α1 isoform 
of NKA regulates cardiac contractility, and that both the α1 
and  α2  isoforms  are  functionally  and  physically  coupled 
with the Na/Ca exchanger in heart [66]. Intracellular sodi-
um concentration ([Na+]i) modulates cardiac contractile and 
electrical activity through Na/Ca exchange (NCX). Upregu-
lation of NCX in heart failure (HF) may magnify the func-
tional impact of altered [Na+]i. Myocyte [Na+]i is elevated in 
HF as a result of higher diastolic Na+ influx (with unaltered 
NKA characteristics). In HF, the combined increased [Na+]i, 
decreased Ca2+ transient, and prolonged action potential all 
profoundly affect cellular Ca2+ regulation, promoting greater 
Ca2+ influx through NCX during action potentials. Notably, 
the elevated [Na+]i may be critical in limiting the contrac-
tile dysfunction observed in HF [67].  The same research 
unit later reported that cardiac NKA regulates intracellular 
Na+, which in turn affects intracellular Ca2+ and contractility 
via the Na+/Ca2+ exchanger. Extracellular K+ concentration 
([K+]) is a central regulator of NKA activity. Phospholem-
man (PLM) has recently been recognized as a critical regula-
tor of NKA in the heart. PLM reduces the intracellular Na+ 
affinity of NKA, an effect relieved by PLM phosphorylation. 
It was tested whether the NKA α1 vs. α2-isoforms have dif-
ferent external K+ sensitivity and whether PLM and PKA 
(Protein Kinase A) activation affects the NKA affinity for K+ 
in mouse cardiac myocytes. And measured the external [K+] 
dependence of the pump current generated by the ouabain-
resistant NKA isoform in myocytes from wild-type (WT) 
mice (that is, current due to NKA -α1) and mice in which the 
NKA isoforms have swapped ouabain affinities (α1 is oua-
bain sensitive and α2 is ouabain resistant) to assess current 
due to NKA -α2. It was found that (1) NKA -α1 has higher 
affinity for K+ than NKA -α2 in cardiac myocytes; (2) PLM 
decreases the apparent external K+ affinity of NKA; and (3) 
phosphorylation of PLM at the cytosolic domain does not 
alter apparent extracellular K+ affinity of NKA [68].  
Regarding isoform regulation, it is hypothesized that a 
primary decrease in cardiac NKA expression would be as-
sociated with a secondary increase in cardiac Na+/Ca++ ex-
changer (NCX)  expression as a homeostatic mechanism to 
blunt an increase in cell Ca++ stores (and vice-versa with an 
increase in NKA). Supporting the hypothesis: in a rat model 
of renovascular hypertension, or after treatment with amio-
darone there are 50% decreases in a-2 levels with 35-40% 
increases in NCX levels in left ventricle, while in the transi-
tion from hypo- to hyperthyroid, there are increases in both 
α-1 (2-fold) and α-2 (8-fold) with decreases in NCX (0.45-
fold).  In  comparison,  in  transgenic  mice  over  expressing 
NCX, there was no secondary change in NKA α-1  or α-2   
levels indicating that primary changes in NCX do not drive 
secondary changes in NKA in the heart. This information 
provides the basis for addressing the significant gaps in our 
understanding of the physiologic, structural and homeostatic 
coupling between sodium pump isoforms and Na+/Ca++ ex-
changers in the heart and how coupling is related to control 
of cardiac contractility in health and disease [69].      
Regulatory role of nitric oxide on NKA in hypertension 
One of the complications accompanying hypertension is the 
increase of intracellular concentration of sodium ions in the 
cardiac tissue and intracellular Na+ homeostasis is based on 
a balance between the influx and efflux of Na+. For the efflux 
of excessive Na+ ions out from the cells is responsible the 
NKA. It has been reported that hypertension was followed 
by remodeling of the Na+-binding site of the NKA molecule 
in the heart as an adaptation to enhanced [Na+]i induced by 
increased blood pressure, independently on the level of NO 
synthesis. On the other hand, the elevated activity of NO 
synthase induced an improvement of the ATP-affinity of the 
enzyme resulting thus in higher efficiency for utilizing the 
substrate ATP. In a situation of both effects, the hyperten-
sion and elevated activity of NO synthase occurred simul-
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taneously, the influence of elevated activity of NO synthase 
seems to have a predominant role in regulating the function 
of cardiac NKA [70].
Oxygen-induced regulation of NKA
The changes in oxygen availability render the adjustment of 
the NKA activity which is a matter of survival for neuronal 
cells. Petrushanko et al used freshly isolated rat cerebellar 
granule cells to study oxygen sensitivity of the NKA func-
tion. Along  with  transport  and  hydrolytic  activity  of  the 
enzyme they have monitored alterations in free radical pro-
duction, cellular reduced glutathione, and ATP levels. Both 
active K+ influx and ouabain-sensitive inorganic phosphate 
production were found to be maximal within the physiologi-
cal pO2 range of 3-5 kPa. Transport and hydrolytic activity of 
the NKA was equally suppressed under hypoxic and hyper-
oxic conditions. The ATPase response to changes in oxygen-
ation was isoform specific and limited to the α1-containing 
isozyme whereas a 2/3-containing isozymes were oxygen 
insensitive. Rapid activation of the enzyme within a narrow 
window of oxygen concentrations did not correlate with al-
terations in the cellular ATP content or substantial shifts in 
redox potential but was completely abolished when NO pro-
duction by the cells was blocked by l-NAME (Nω-nitro-l-
arginine) . Taken together their observations suggest that NO 
and its derivatives are involved in maintenance of high NKA 
activity under physiological conditions [71].
NKA regulates sperm capacitation    
In 2009, Newton et al observed that NKA was involved in 
the  regulation  of  tyrosine  phosphorylation  in  sperm  pro-
teins  through  receptor  tyrosine  kinase,  non-receptor  type 
protein kinase, and protein kinases A and C. It was inferred 
that the inhibition of NKA induced tyrosine phosphoryla-
tion and capacitation through multiple signal transduction 
pathways, imparting fertilizing ability in bovine sperm. It 
is an interesting report documenting both the involvement 
of ATP1A4 in the regulation of bovine sperm capacitation 
and that fresh bovine sperm capacitated by the inhibition of 
NKA can fertilize oocytes in vitro [72]. NKA acts as a sig-
naling molecule during bovine sperm capacitation. Binding 
of ouabain to NKA inhibited motility (decreased progressive 
motility, average path velocity, and curvilinear velocity) and 
induced tyrosine phosphorylation and capacitation but did 
not increase intracellular calcium levels in spermatozoa. Fur-
thermore, binding of ouabain to NKA induced depolarization 
of sperm plasma membrane. Therefore, binding of ouabain 
to NKA induced sperm capacitation through depolarization 
of sperm plasma membrane and signaling via the tyrosine 
phosphorylation pathway without an appreciable increase in 
intracellular calcium. Thundathil et al claimed in 2006, such 
finding to be the first report concerning the signaling role of 
NKA in mammalian sperm capacitation [73].   
Cell volume regulation through NKA
Excessive alterations of cell volume must be avoided for the 
survival of human and animal cells. The osmolarity amassed 
by  cellular  accumulation  of  organic  substances  must  be 
compensated by lowering cytosolic ion concentrations. The 
NKA extrudes Na+ in exchange for K+, which can permeate 
the cell membrane through K+ channels. K+ exit generates a 
cell-negative potential difference across the cell membrane, 
driving the exit of anions such as Cl-. The low cytosolic Cl- 
concentrations counterbalance the excess cellular osmolar-
ity by organic substances. Cell volume regulation following 
cell swelling involves releasing ions through activation of K+ 
channels and/or anion channels, KCl-cotransport, or parallel 
activation of K+/H+ exchange and Cl-/HCO3
- exchange. Cell 
volume regulation following cell shrinkage involves accu-
mulation of ions through activation of Na+, K+, 2Cl- co-trans-
port, Na+/H+ exchange in parallel to Cl-/HCO3
- exchange, or 
Na+ channels. The Na+ taken up is extruded by the NKA in 
exchange for K+. Shrunken cells further accumulate organic 
osmolytes such as sorbitol and glycerophosphorylcholine, 
and monomeric amino acids by altered metabolism and myo-
inositol (inositol), betaine, taurine, and amino acids by Na+ 
coupled transport. They release osmolytes during cell swell-
ing. Challenges of cell volume homeostasis include trans-
port, hormones, transmitters, and drugs. Moreover, altera-
tions of cell volume participate in the machinery regulating 
cell proliferation and apoptotic cell death. Deranged cell vol-
ume regulation significantly contributes to the pathophysiol-
ogy of several disorders such as liver insufficiency, diabetic 
ketoacidosis, hypercatabolism, fibrosing disease, sickle cell 
anemia, and infection [74].
NKA involvement in ionic regulation of apoptosis
The loss of cell volume, chromatin condensation, internu-
cleosomal  DNA  fragmentation,  and  apoptotic  body  for-
mation are the distinct features of the apoptosis, an active 
process.    Among  the  classical  characteristics  that  define 
apoptosis, the loss of cell volume has become a very im-
portant component of the programmed cell death process. 
Changes in cell volume result from alterations in the homeo-
stasis of ions and in particular the movement of Na+ and K+ 
ions. Most living cells have a high concentration of intracel-
lular K+ and a low concentration of intracellular Na+. This 
is in contrast to the outside of the cell, where there is a high 
concentration of extracellular Na+ and a low concentration of 
extracellular K+. Thus, a concentration gradient exists for the 
loss and gain of intracellular K+ and Na+, respectively. This 
gradient is maintained through the activity of various ionic 
channels and transporters, but predominantly the activity of 
the NKA. During apoptosis, there is compelling evidence in-
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dicating an early increase in intracellular Na+ followed by a 
decrease in both intracellular K+ and Na+ suggesting a regu-
latory role for these cations during both the initial signalling, 
and the execution phase of apoptosis. Recent studies have 
shown that the NKA is involved in controlling perturbations 
of Na+ and K+ homeostasis during apoptosis, and that anti-
apoptotic Bcl-2 and Bcl-XL molecules influence these ionic 
fluxes. Finally, understanding the regulation or deregulation 
of ionic homeostasis during apoptosis is critical to facilitate 
the treatment of cardiovascular, neurological, and renal dis-
eases where apoptosis is known to play a major role [75].
NKA activity in rheumatoid arthritis patients
The NKA activity was significantly lower in Rheumatoid 
Arthritis  (RA)  patients  than  in  both  healthy  controls  and 
patients with osteoarthritis or gout. A slight but significant 
increase in Nai was observed in rheumatoid subjects. It is hy-
pothesized that the decrease in the NKA activity in RA may 
be the result of a defective expression of membrane proteins, 
which is probably related to the altered cell sensitivity ob-
served [76]. Kiziltunç et al have also reported decrease in 
NKA in rheumatoid arthritis patients [77].
Sepsis correlated NKA activity
Hsieh et al have reported that during sepsis, membrane al-
terations occur and result in an increased cellular Na+ con-
tent. (Vmax and v) was significantly stimulated, possibly as 
a consequence of a secondary response to the elevated Na+ of 
cells. Both cellular Na+ and Vmax were correlated well with 
the severity of sepsis, suggesting that these altered transport 
parameters may reflect the progress of sepsis [78].
NKA in relation to neurological disorders
The cytosol of nerve endings are reported to contain the fac-
tors regulating the activity of synaptosomal NKA. These fac-
tors stimulated by neurotransmitters activate the NKA system 
affecting the phosphorylating intermediates of the enzyme 
and putting the NKA system in the mode of simultaneous 
transport of Na and K ions [79]. Psychiatric abnormalities 
have been described in primary neurological disorders like 
multiple sclerosis, primary generalized epilepsy, Parkinson’s 
disease, subacute sclerosing panencephalitis (SSPE), central 
nervous system glioma, and syndrome X with vascular de-
mentia. In 2003, Kurup and Kurup considered pertinent to 
compare monoamine neurotransmitter pattern in schizophre-
nia with those in the disorders mentioned above. The end 
result of neurotransmission is changes in membrane NKA 
activity. Membrane NKA inhibition can lead to magnesium 
depletion, which can lead to an upregulated isoprenoid path-
way. The isoprenoid pathway produces three important me-
tabolites: digoxin; an endogenous membrane NKA inhibitor; 
ubiquinone, a membrane antioxidant and component of mi-
tochondrial electron transport chain, and dolichol, important 
in N-glycosylation of protein. The serum/plasma levels of 
digoxin, dolichol, ubiquinone, magnesium, HMG CoA re-
ductase activity, and RBC NKA activity were estimated in 
all these disorders. The result showed that the concentration 
of serum tryptophan and serotonin was high and serum tyro-
sine, dopamine, adrenaline, and nor-adrenaline low in all the 
disorders studied. The plasma HMG CoA reductase activ-
ity, serum digoxin, and serum dolichol levels were high and 
serum ubiquinone levels, serum magnesium, and RBC NKA 
activity were low in all these disorders [80].
NKA associated with migraine pathophysiology
Cerebrospinal fluid sodium concentration ([Na+]csf) increases 
during migraine, but the cause of the increase is not known. 
In 2009, Harrington et al analyzed biochemical pathways 
that influence [Na+]csf to identify mechanisms that are consis-
tent with migraine and inferred that increased capillary endo-
thelial cell (CEC) NKA transporter (NKAT) activity is prob-
ably the primary cause of increased [Na+]csf. Physiological 
fluctuations of all NKAT regulators in blood, many known 
to be involved in migraine, were monitored by receptors on 
the luminal wall of brain CECs; signals then transduced to 
their abluminal NKATs that alter brain extracellular sodium 
([Na+]e) and potassium ([K+]e). They proposed a theoreti-
cal mechanism for aura and migraine when NKAT activity 
shifts outside normal limits: (1) CEC NKAT activity below a 
lower limit increases [K+]e, facilitates cortical spreading de-
pression, and causes aura; (2) CEC NKAT activity above an 
upper limit elevates [Na+]e, increases neuronal excitability, 
and causes migraine; (3) Migraine-without-aura may arise 
from CEC NKAT over-activity without requiring a prior de-
crease in activity and its consequent spreading depression; 
(4) migraine triggers disturb, and treatments improve, CEC 
NKAT  homeostasis;  (5)  CEC  NKAT-induced  regulation 
of neural and vasomotor excitability coordinates vascular 
and neuronal activities, and includes occasional pathology 
from CEC NKAT-induced apoptosis or cerebral infarction 
[81]. As mentioned above the NKA is an ion-translocating 
transmembrane protein that actively maintains the electro-
chemical gradients for Na+ and K+ across the plasma mem-
brane. The functional protein is a heterodimer comprising a 
catalytic α-subunit (four isoforms) and an ancillary β-subunit 
(three isoforms). Mutations in the α2-subunit have recently 
been implicated in familial hemiplegic migraine type 2, but 
almost no thorough studies of the functional consequences 
of these mutations have been provided. However, in 2005 
Koenderink et al [82] investigated the functional properties 
of the mutations L764P and W887R in the human NKA α2-
subunit upon heterologous expression in Xenopus oocytes. 
No NKA-specific pump currents could be detected in cells 
expressing these mutants. The binding of radiolabelled [3H] 
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ouabain to intact cells suggested that this could be due to 
a lack of plasma membrane expression. However, plasma 
membrane isolation showed that the mutated pumps are well 
expressed at the plasma membrane. 86Rb+-flux and NKA ac-
tivity measurements demonstrated that the mutants are inac-
tive. Therefore, the primary disease-causing mechanism is 
loss-of-function of the NKA α2-isoform.
NKA expression, regulation and function in the lens
The required concentrations of sodium and potassium in lens 
cells are maintained by NKA. NKA activity is different in 
the two cell types that make up the lens, epithelial cells and 
fibers; specific activity in the epithelium is higher than in 
fibers. In some parts of the fiber mass NKA activity is barely 
detectable. Several reports suggest that NKA-mediated ion 
transport by the epithelium contributes significantly to the 
regulation of ionic composition in the entire lens. In some 
species different NKA isoforms are present in epithelium 
and fibers but in general, fibers and epithelium express a sim-
ilar amount of NKA protein. The turnover of NKA by pro-
tein synthesis may contribute to preservation of high NKA 
activity in the epithelium. In ageing lens fibers, oxidation, 
and glycation may decrease NKA activity. NKA activity in 
lens fibers and epithelium also may be subject to regulation 
as the result of protein tyrosine phosphorylation. Moreover, 
activation of G protein-coupled receptors by agonists such as 
endothelin-1 elicits changes of NKA activity. The asymmet-
rical distribution of NKA activity in the epithelium and fibers 
may contribute to ionic currents that flow in and around the 
lens. Studies on human cataract and experimental cataract in 
animals reveal changes of NKA activity but no clear pattern 
is evident. However, there is a convincing link between ab-
normal elevation of lens sodium and the opacification of the 
lens cortex that occurs in age-related human cataract [83].
Role of NKA in lung edema clearance 
In 2002 Sznajder et al [84] have reported that acute hypox-
emic respiratory failure is a consequence of edema accumu-
lation due to elevation of pulmonary capillary pressures and/
or increases in permeability of the alveolocapillary barrier. 
It has been recognized that lung edema clearance is distinct 
from edema accumulation and is largely affected by active 
Na+ transport out of the alveoli rather than reversal of the 
Starling forces, which control liquid flux from the pulmo-
nary  circulation  into  the  alveolus. The  alveolar  epithelial 
NKA has an important role in regulating cell integrity and 
homeostasis. In the last 15 years, NKA has been localized 
to the alveolar epithelium and its contribution to lung edema 
clearance has been appreciated. The importance of the al-
veolar epithelial NKA function is reflected in the changes in 
the lung’s ability to clear edema when the NKA is inhibited 
or increased. An important focus of the ongoing research is 
the study of the mechanisms of NKA regulation in the alveo-
lar epithelium during lung injury and how to accelerate lung 
edema clearance by modulating NKA activity. Report from 
Matthay et al [85] emphasized that the rate of fluid transport 
can be increased in most species, including the human lung, 
by cAMP stimulation. Catecholamine-independent mecha-
nisms, including hormones, growth factors, and cytokines, 
can also upregulate epithelial fluid clearance in the lung. The 
new insight into the role of the distal lung epithelium in ac-
tively regulating lung fluid balance has important implica-
tions for the resolution of clinical pulmonary edema.
Hormonal regulation of  NKA
The patients often complain of muscular weakness, exercise 
intolerance, cramps and excessive fatigability during thyroid 
deficiency. Hypothyroidism induces a metabolic myopathy, 
with a fall of the energetic production, and especially of the 
mitochondrial metabolism. This is due to a global inhibition 
of  the  main  oxidative  pathways  (substrate  incorporation, 
substrate oxidation) and of the respiratory chain. A dimin-
ished energetic consumption is partially related to a transi-
tion in the myosin isoforms, which express a slower ATPase, 
and to an impairment of the trans-sarcolemic transports. The 
decreased number of NKA dependent pumps could imply an 
abnormal intracellular Na+ level and explain the frequent dis-
orders of the membrane excitability [86]. T3 (3, 3’, 5-triio-
do-L-thyronine) plays an important role in cell survival and 
differentiation. Nongenomic regulation of phosphatidylino-
sitol 3-kinase and downstream molecules by T3 is being rec-
ognized in different tissues. Upregulation of alveolar NKA 
is one such molecule, which plays an important role in re-
moval of edema fluid from the alveolar space. These effects 
are rapid and do not require direct nuclear gene transcription 
[87]. In 2007, Phakdeekitcharoen et al have reported the first 
evidence that, in human skeletal muscles, thyroid hormone 
upregulates the NKA protein expression at least, in part, at 
mRNA level, and the α2 and β1 subunits play the important 
role in this regulation [88].
Aldosterone, a major regulator of Na transport by the 
collecting duct, stimulates NKA activity through both re-
cruitment of intracellular pumps and increased total amounts 
of Na pump subunits. And we know that the collecting duct 
is the site of final sodium reabsorption according to Na bal-
ance requirements. Vasopressin and cAMP, its second mes-
senger,  stimulate  NKA  activity  within  minutes  through 
translocation of sodium pumps from a brefeldin A-sensitive 
intracellular pool to the plasma membrane. Dysregulation of 
collecting duct NKA activity is at least in part responsible of 
the sodium retention observed in nephritic syndrome. Thus, 
aldosterone,  vasopressin,  and  intracellular  sodium  control 
the cell surface expression of NKA and translocation from 
intracellular stores is a major mechanism of regulation of 
NKA activity in collecting duct principal cells [89].
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In the kidney, the collecting duct (CD) is the site of fi-
nal sodium reabsorption, according to Na+ balance require-
ments. In this segment of the renal tubule, principal cells 
may reabsorb up to 5% of the filtered sodium. The driving 
force for this process is provided by the basolateral NKA 
(sodium pump). NKA activity and expression in the CD are 
modulated  physiologically  by  hormones  (aldosterone,  va-
sopressin, and insulin) and non-hormonal factors including 
intracellular (Na+) and extracellular osmolality [90].
In 2008, Kamenicky et al [91] observed that acrome-
galic GC rats (genetic catalepsy rats), which are chronically 
exposed to very high levels of GH (Growth Hormone), ex-
hibited a decrease of furosemide-induced natriuresis and an 
increase of amiloride-stimulated natriuresis compared with 
Wistar rats (controls). Enhanced NKA activity and altered 
proteolytic maturation of epithelial sodium channel (ENaC) 
subunits in the cortical collecting ducts (CCDs) of GC rats 
provided additional evidence for an increased sodium reab-
sorption in the late distal nephron under chronic GH excess. 
They reported that GH directly controls sodium reabsorption 
in CCD cells is supported by: (1) stimulation of transepi-
thelial sodium transport inhibited by GH receptor antagonist 
pegvisomant; (2) induction of alpha-ENaC mRNA expres-
sion; and (3) identification of signal transducer and activator 
of transcription 5 binding to a response element located in 
the alpha-ENaC promoter, indicative of the transcriptional 
regulation of alpha-ENaC by GH. Their findings provide 
the first evidence that GH, in concert with IGF-I, stimulates 
ENaC-mediated sodium transport in the late distal nephron, 
accounting for the pathogenesis of sodium retention in ac-
romegaly.
Role of NKA in preeclampsia
Preeclampsia is a disorder of pregnancy characterized by 
pregnancy-induced  hypertension  (≥140  mm  Hg  systolic 
and / or ≥ 90 mm Hg diastolic blood pressure), new-onset 
proteinuria (≥ 300 mg protein/day), and edema occurring in 
the second half of pregnancy. It is a disease characterized by 
hypertension and proteinuria but can manifest many abnor-
malities. We have earlier reported that preeclampsia involves 
the significant increase in the plasma concentrations of ni-
tric oxide [92]. As mentioned above the elevated activity of 
NO synthase induced an improvement of the ATP-affinity of 
NKA resulting thus in higher efficiency for utilizing the sub-
strate ATP. Some of the best documented alterations involve 
changes in the handling of sodium ion both on the systemic 
and on the cellular level. A majority of studies support an 
increase in peripheral cell sodium concentration. This would 
suggest a defect in NKA or sodium pump activity. Direct 
study of cellular sodium pump activity provides suggestive 
but not unequivocal support for this decreased sodium pump 
activity. Other evidence indicates increased circulating con-
centrations of a sodium pump inhibitor in most, but not all, 
studies of preeclampsia.  Together, current research argues 
more strongly in favor of derangements of cell sodium han-
dling perhaps mediated by circulating sodium pump inhibi-
tors leading often to increased cell sodium. Such an increase 
of cell sodium in vascular tissue has previously been shown 
to enhance vascular sensitivity to vasoconstrictor agents or 
lead directly to increased vasoconstriction [93]. 
Role of NKA in carcinoma
In 2003, Rajasekaran et al have reported that NKA func-
tion is necessary for the formation and maintenance of tight 
junctions in epithelial cells, suggesting that NKA plays an 
essential role in regulating the trans  port and polarized phe-
notype of epithelial cells. Loss of the polarized phenotype of 
epithelial cells is a characteristic of carcinoma and correlates 
with their inva  siveness and metastatic potential. Consistent 
with an important role for NKA in the regulation of polar-
ized phenotype of epithelial cells, both NKA enzyme activity 
and subunit levels are re  duced in carcinoma [94]. NKA-β 
levels were highly reduced in an invasive form of human 
renal clear cell carcinoma [94], androgen-dependent prostate 
cancer [95], in early stages of urothelial cancer, as well as in 
poorly differentiated, highly motile carcinoma cell lines ob-
tained from various tissues [96],suggesting a functional link 
between reduced NKA-β ex  pression and cancer progression. 
In contrast, the levels of NKA-α did not reveal a consistent 
pattern in different car  cinomas. Increased cell motility is a 
prerequisite for invasion and metastasis, and in general most 
of the invasive carcinoma cell lines are highly motile.  
Recently, it has been shown that NKA β localizes to la-
mellipodia and suppresses cell motility by a novel signaling 
mechanism involving a cross-talk between NKA α1-subunit 
(NKA α) and NKA β with proteins involved in phosphati-
dylinositol 3-kinase (PI3-kinase) signaling pathway. Further, 
that NKA α associates with the regulatory subunit of PI3-
kinase and NKA β binds to annexin II. These molecular in-
teractions locally activate PI3-kinase at the lamellipodia and 
suppress cell motility in MSV-MDCK cells, independent of 
NKA ion transport activity. Thus, these results demonstrate a 
new role for NKA in regulating carcinoma cell motility [97].
Earlier studies demonstrated altered NKA subunit ex-
pression in renal clear cell carcinoma and an association of 
subunit levels with the prediction of recurrent bladder can-
cer. In 2008, Seligson et al [98] determined the clinical as-
sociation of protein expression patterns of the NKA α1 and 
β1-subunits in renal clear cell carcinoma using tissue micro-
arrays with linked clinicopathological data. However, their 
results suggest that NKA α1-subunit expression patterns may 
be a useful clinical prognosticator for renal clear cell carci-
noma. The NKA β1-subunit was not found to be a useful 
prognosticator in this setting.
The sodium pump (NKA) could be a target for the devel-
opment of anticancer drugs as it serves as a signal transducer, 
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it is a player in cell adhesion and its aberrant expression and 
activity are implicated in the development and progression of 
different cancers. Cardiotonic steroids (CTS), are the natural 
ligands and inhibitors of the sodium pump and this supports 
the possibility of their development as anticancer agents tar-
geting overexpressed NKA α-subunits. In 2008, Mijatovic 
et al have emphasized that targeting over-expressed NKA 
α-subunits using novel CTS might open a new era in anti-
cancer therapy and bring the concept of personalized medi-
cine from aspiration to reality. Clinical data are now needed 
to further support this proposal. Furthermore, future medici-
nal chemistry should optimize new anticancer CTS to target 
NKA α-subunits with the aim of rendering them more potent 
and less toxic [99].
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